Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

A new microneedle patch helps repair spinal cord injuries by reducing scarring and promoting nerve growth.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.